Kam Lawrence 13F Holdings · last filed Q4 2019
Kam Lawrence reported 7 securities worth $97.38M in its SEC 13F filing for Q4 2019 (period ended 2019-12-31). Top holdings: ADVM (47.83%), RGNX (19.59%), SRPT (14.93%). Among its top 25 positions this quarter: 7 new.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ADVM | ADVERUM BIOTECHNOLOGIES INC | $46.6M | 47.83% | 4.0M | New |
| 2 | RGNX | REGENXBIO INC | $19.1M | 19.59% | 465,664 | New |
| 3 | SRPT | SAREPTA THERAPEUTICS INC | $14.5M | 14.93% | 112,689 | New |
| 4 | GNW | GENWORTH FINL INC | $9.2M | 9.48% | 2.1M | New |
| 5 | FENC | FENNEC PHARMACEUTICALS INC | $5.4M | 5.56% | 834,689 | New |
| 6 | SPNT | THIRD PT REINS LTD | $2.4M | 2.45% | 227,185 | New |
| 7 | TROX | TRONOX HOLDINGS PLC | $149,000 | 0.15% | 13,055 | New |
Source: SEC Form 13F filings · as of 2019-12-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR